Related Experiment Video
Updated: Jan 3, 2026

09:53
An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
Published on: August 25, 2017
9.3K
Towards Understanding KSHV Fusion and Entry
1Biological Mimetics Inc., 124 Byte Drive, Frederick, MD 21702, USA.
Viruses
|November 23, 2019
Summary
Discover how Kaposi's sarcoma-associated herpesvirus (KSHV) enters host cells. This review details viral glycoproteins and their roles in cell attachment, internalization, and membrane fusion for KSHV infection.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- Viral entry mechanisms are crucial for pathogenesis and therapeutic strategies.
- Herpesviruses utilize multiple envelope glycoproteins for infection, involving attachment, receptor interaction, and membrane fusion.
- Recent advances have elucidated herpesvirus entry pathways at the molecular level.
Purpose of the Study:
- To review discoveries on Kaposi's sarcoma-associated herpesvirus (KSHV) cell entry.
- To focus on the roles of viral glycoproteins in KSHV attachment, internalization, and fusion.
- To understand KSHV's interaction with host cells and entry pathways.
Main Methods:
- Literature review of recent findings on KSHV entry.
- Analysis of the functions of KSHV envelope glycoproteins.
- Examination of molecular interactions during viral entry and fusion.
Main Results:
- Herpesvirus entry involves a cascade of interactions between viral glycoproteins and host cell receptors.
- Multiple viral and cellular molecules orchestrate virus-host cell binding, internalization, and membrane fusion.
- Specific glycoproteins are essential for KSHV's ability to infect critical cell types.
Conclusions:
- Understanding KSHV glycoprotein mechanisms is key to developing targeted antiviral therapies.
- The complexity of herpesvirus entry highlights diverse host-pathogen interactions.
- Further research into KSHV entry pathways can reveal novel therapeutic targets.
Related Concept Videos
Retrovirus Life Cycles
49.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Retroviruses
14.5K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
14.5K
Mechanisms of Retrovirus-induced Cancers
6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Fusion of Secretory Vesicles with the Plasma Membrane
16.4K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
16.4K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
Receptor-mediated Endocytosis
7.4K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.4K

